Industry News
Biotechnology Industry News

Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam
Dicerna narrows focus for kidney drug after mixed data, setting up head-to-head market battle with rival Alnylam badams Tue, 10/19/2021 - 08:57
Atea and Roche’s COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data
Atea and Roche's COVID-19 antiviral flunks phase 2, prompting switch that will delay pivotal data ntaylor Tue, 10/19/2021 - 08:11
Biogen, Sage plot 2022 filing for zuranolone approval, furthering turnaround of depression drug
Biogen, Sage plot 2022 filing for zuranolone approval, furthering turnaround of depression drug ntaylor Tue, 10/19/2021 - 07:33
Sofinnova bulks out VC shop with a hefty $548M as it zeroes in on early-stage European biotechs
Sofinnova bulks out VC shop with a hefty $548M as it zeroes in on early-stage European biotechs badams Tue, 10/19/2021 - 03:44
A new target in multiple myeloma? TAK1 blocker boosts chemo’s cancer-killing power in preclinical study
A new target in multiple myeloma? TAK1 blocker boosts chemo's cancer-killing power in preclinical study arlene.weintraub Mon, 10/18/2021 - 09:31
FDA rejects Omeros transplant drug over difficulties estimating its effect
FDA rejects Omeros transplant drug over difficulties estimating its effect ntaylor Mon, 10/18/2021 - 07:57
Biogen’s ALS drug has failed phase 3. Will FDA approve anyway?
Biogen's ALS drug has failed phase 3. Will FDA approve anyway? ntaylor Mon, 10/18/2021 - 05:13
Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite badams Fri, 10/15/2021 - 10:02
Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load in hamsters
Inhalable anti-COVID-19 antibody from TFF and Augmenta tamps down viral load in hamsters arlene.weintraub Fri, 10/15/2021 - 08:26
AstraZeneca delivers rare win for treme in liver cancer, bouncing back from flops to beat Bayer’s Nexavar
AstraZeneca delivers rare win for treme in liver cancer, bouncing back from flops to beat Bayer's Nexavar ntaylor Fri, 10/15/2021 - 07:58
Chinese biopharma powerhouse continues charge into siRNA with Silence R&D pact
Chinese biopharma powerhouse continues charge into siRNA with Silence R&D pact ntaylor Fri, 10/15/2021 - 04:33
Protein that manipulates gene expression inside the cell nucleus could inspire new RSV drugs, vaccines
Protein that manipulates gene expression inside the cell nucleus could inspire new RSV drugs, vaccines klahucik Thu, 10/14/2021 - 10:23
Omega, eyeing new uses for genome-tuning tech, taps Stanford to find ocular disease targets
Omega, eyeing new uses for genome-tuning tech, taps Stanford to find ocular disease targets ntaylor Thu, 10/14/2021 - 08:48
OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial
OnKure sets Diamond in C-suite ahead of Pfizer drug combo trial ntaylor Thu, 10/14/2021 - 08:03
After 15 years helping lead early cancer research at Genentech, Malek jumps ship to run Novartis’ NIBR oncology unit
After 15 years helping lead early cancer research at Genentech, Malek jumps ship to run Novartis' NIBR oncology unit badams Thu, 10/14/2021 - 04:33
Novel protein degrader against ‘undruggable’ cancer target inhibits tumors in mice
Novel protein degrader against 'undruggable' cancer target inhibits tumors in mice aliu Wed, 10/13/2021 - 13:01
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Aum bags $27M to hit cancer targets pursued by Bayer, Roche ntaylor Wed, 10/13/2021 - 08:32
Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem
Apnimed sees positives in midstage data for its attempt at drugging the sleep apnea problem badams Wed, 10/13/2021 - 04:58
UPDATE: CRISPR hails safety, efficacy of off-the-shelf CAR-Ts, but stock slides amid durability doubts
UPDATE: CRISPR hails safety, efficacy of off-the-shelf CAR-Ts, but stock slides amid durability doubts ntaylor Wed, 10/13/2021 - 04:32
J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes
J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes ntaylor Tue, 10/12/2021 - 08:39

